Facebook

Download our Free App

Sumfest banner

Subscribe now

captcha 
New Alzheimer's drug breakthrough in the UK

New Alzheimer's drug breakthrough in the UK Featured

Press Release Written by  Tuesday, 06 September 2016 01:26 font size decrease font size increase font size 0
Rate this item
(0 votes)
Scientists said they were amazed to find that patients treated with the highest dose of the antibody drug aducanumab experienced an almost complete clearance of the amyloid plaques that prevent brain cells communicating, leading to irreversible memory loss and cognitive decline.

 

Crucially they also found that after six months of the treatment, patients stopped deteriorating compared with those taking a placebo, suggesting that their dementia had been halted.

In the trial, which was reported in the journal Nature, scientists tested varying levels of the drug over a year, as well as giving one group a placebo. They found that more amyloid was removed as the dose increased. Brain scans of those given the highest dose shown virtually no amyloid left at all.

 

The drug is likely to be most effective for patients in the very earliest stages of Alzheimer’s disease, or those who have not yet begun to show symptoms. Several universities are working on early blood tests for dementia which could pick the disease up a decade or more before the first physical signs appear.

 

Dementia experts and charities said that the breakthrough offered real hope for the future treatment of Alzheimer’s disease

Read 394 times Last modified on Monday, 05 September 2016 19:45

Leave a comment

Make sure you enter all the required information, indicated by an asterisk (*). HTML code is not allowed.

Search

Latest Comments